SU
Sudeep Pharma Ltd (SUDEEPPHRM)
₹1,070.00
Mkt cap
₹12,764 Cr
P/E ratio
67.80
P/B
12.62
Div yield
0.13%
ROE
25.20%
ROCE
28.20%
EPS (TTM)
₹15.78
Book value
₹85
52W range
524–1,378
Sector
Healthcare
Price history
Previous close
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries. [1]
NSE SUDEEPPHRMBSE 544619
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthHigh
TechnicalsNeutral
52-week range
−22.35% from high₹1,070
₹524+104.18% from low₹1,378
Current
₹1,070.00
Prev close
₹1,134.00
Day
−5.64%
Price performance
1D
−5.64%
1W
+10.74%
1M
−10.48%
3M
+24.96%
6M
+54.45%
1Y
—
YTD
+79.29%
Financials
Revenue, profit & margin
P/E ratio
67.8×
SUDEEPPHRM is 97% above the sector median of 34.5×
SUDEEPPHRM67.8×
Sector median34.5×
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 116 | 158 | 125 | 163 | 172 | 182 | 158 | 197 | |
| Expenses | 85 | 76 | 99 | 81 | 107 | 112 | 120 | 103 | 123 | |
| Operating Profit | 63 | 39 | 59 | 44 | 55 | 60 | 63 | 55 | 73 | |
| OPM % | 43% | 34% | 37% | 35% | 34% | 35% | 34% | 35% | 37% | |
| Other Income | 2 | 2 | 4 | 5 | 10 | 7 | 6 | 5 | 6 | |
| Interest | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 | 3 | |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | |
| Profit before tax | 62 | 38 | 58 | 44 | 60 | 62 | 63 | 54 | 71 | |
| Tax % | 21% | 24% | 24% | 29% | 21% | 23% | 23% | 25% | 27% | |
| Net Profit | 49 | 29 | 44 | 31 | 47 | 48 | 49 | 41 | 52 | |
| EPS in Rs | 5.80 | 2.95 | 4.54 | 3.17 | 4.71 | 4.20 | 4.33 | 3.59 | 4.56 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202676.16%Promoter
Promoters76.16%
FIIs2.93%1.12
DIIs14.06%1.58
Public6.87%0.48
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,761.00 | 33.45 | 4,22,523 | 0.91% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,664.00 | 86.11 | 2,56,549 | 0.31% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,580.00 | 80.24 | 1,74,208 | 0.83% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,244.00 | 90.49 | 1,21,246 | 0.09% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,184.40 | 24.27 | 1,18,144 | 0.08% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Dr Reddy's Labs | ₹1,345.00 | 40.10 | 1,12,265 | 0.59% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,358.00 | 35.33 | 1,09,709 | 0.96% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Sudeep Pharma | ₹1,130.10 | 67.77 | 12,764 | 0.13% | 52 | +12.46% | 197 | +20.92% | 28.18% |
| Median: 159 Co. | ₹439.10 | 34.49 | 1,934 | 0.08% | 14 | +22.88% | 170 | +18.91% | 15.11% |
Filings
Annual reports1
Concall transcripts14
Credit ratings2
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 29 Oct - Audio recording of the 29 October 2026 earnings call uploaded.Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Oct - Submission of Newspaper Advertisement for unaudited Financials for the Quarter and Half Year ended 30th September 2026.Announcement under Regulation 30 (LODR)-Investor Presentation 28 OctUnaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026 28 OctBoard Meeting Outcome for Outcome Of Board Meeting Held On 28Th October 2026 28 Oct - Board approved Q2 FY27 results on 28 Oct 2026; consolidated profit rose to ₹5,181.11 lakh.